OFDT's working organisation
The French Monitoring Centre for Drugs and Drug Addiction (OFDT) relies on 2 Scientific Units (DATA and FOCUS), a General Secretariat, a communication and an accountancy department. The tasks of the Centre are carried out by a team of experts and researchers from different disciplines (statistics, demographics, epidemiology, economics, medicine, pharmacology, sociology) as well as administrative and technical staff.
This organisation aims to strengthen our capacity for studies, to develop synergies and partnerships while ensuring promotion and dissemination of our work.
Organisational chart (October 2021)
Directorate
Julien Morel d'Arleux
Director
Ivana Obradovic
Deputy director
Communication
Julie-Emilie Adès
Communication officer
"Data" Unit
Stanislas Spilka
Head of unit
Léo Bouthier
Scientific analyst
Alex Brissot
Scientific analyst
Vincent Eroukmanoff
Scientific analyst
Michel Gandilhon
Scientific analyst
Eric Janssen
Scientific analyst
Olivier Le Nézet
Scientific analyst
Magali Martinez
Scientific analyst
Anna Ndiaye Delepoulle
Scientific analyst
Antoine Philippon
Scientific analyst
"Focus" Unit
Fabrice Guilbaud
Head of unit
Agnès Cadet-Taïrou
Scientific analyst
Victor Detrez
Scientific analyst
Marc-Antoine Douchet
Scientific analyst
Laura Duprat
Scientific analyst
Clément Gérome
Scientific analyst
Maitena Milhet
Scientific analyst
Carine Mutatayi
Scientific analyst
Paul Neybourger
Scientific analyst
Caroline Protais
Scientific analyst
Clément Picot-Ngo
Scientific analyst
General Secretariat
Virginie Martin
Head of unit
Margaux Blanchon
Legal officer
Mickael da Silva
Assistant
Thierry Delprat
Webmaster
Cristina Díaz-Gómez
Scientific analyst
Anne de l'Eprevier
Liaison officer with EMCDDA
Isabelle Michot
Information officer
Frédérique Million
Graphic designer
Financial resources
Pierre-Piquemal-Lagorre
Accountant
Laurence Grandjean
Deputy accountant
Mickael Da Silva
Accounting assistant
Drugs in Europe
2021 EMCDDA European Drug Report
COVID-19
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
Drug markets
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
